What Pope Leo XIV’s lung cancer update can teach readers about early detection
The Vatican says Pope Leo XIV’s lung cancer was localized and that no further treatment is planned after surgery. The case highlights how incidental findings, surgery, and follow-up shape lung cancer care.
When a Breast Lump Is Dismissed, Delayed Diagnosis Can Follow
A CBS News report highlights how a breast lump was initially minimized, underscoring why new breast changes deserve timely medical evaluation and follow-up.
What to Know Before Choosing a Galleri Cancer Blood Test
A Washington Post health column explores the appeal of Galleri, a multi-cancer blood test. The evidence suggests promise, but major questions remain about benefits, harms, and who should consider it.
Why a Lung Nodule Sometimes Leads to Surgery
Pope Leo XIV’s planned lung surgery highlights a common medical reality: a nodule can be harmless, but in some cases doctors remove it to get a clear diagnosis.
Why Older Hereditary Cancer Tests May Need a Second Look
Newer hereditary cancer panels can detect more DNA changes than early BRCA-era tests, which means some people who once tested negative may want to ask whether retesting makes sense.
Why Breast Cancer Care Often Needs a More Individual Approach as People Age
Research and recent reporting point to a familiar but still unresolved problem in breast cancer care: one-size-fits-all screening and treatment can miss important differences in risk, tumor biology, and overall health.
Breast Cancer Risk Tools Are Getting Closer to Patients — But the Evidence Still Matters
New AI-powered breast cancer risk tools are moving beyond the clinic and into patient-facing apps, but experts still urge caution about accuracy, equity, and how results should guide screening.
Breast Cancer Is Rising in Younger Women: What Adults 45+ Should Know
New CDC data show breast cancer is rising slowly in younger women. Here’s what that means for screening, dense breasts, family history and midlife care.